Selvita Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Public

  • Employees
  • 433

Employees

  • Stock Symbol
  • SLV

Stock Symbol

  • Investments
  • 5

  • Share Price
  • $4.51
  • (As of Friday Closing)

Selvita General Information

Description

Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organizations in Europe. It also develops bioinformatics solutions supporting innovative projects at preclinical stages. It also provides services provided to external contractors are in the field of chemistry, analytics, regulatory, biochemistry and cell biology and also the integrated research and development projects.

Contact Information

Website
www.selvita.com
Formerly Known As
Selvita CRO
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Hexagon
  • Ulica Podole 79
  • Krakow, 30-394
  • Poland
+48 12
Primary Industry
Drug Discovery
Stock Exchange
WAR
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • Hexagon
  • Ulica Podole 79
  • Krakow, 30-394
  • Poland
+48 12

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Selvita Stock Performance

As of 13-Nov-2026, Selvita’s stock price is $4.51. Its current market cap is $82.8M with 18.4M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$4.51 $4.54 $3.92 - $13.53 $82.8M 18.4M 35.5K -$0.03

Selvita Financials Summary

As of 30-Jun-2026, Selvita has a trailing 12-month revenue of $92.9M.

In Thousands,
USD 		TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 194,713 268,747 272,994 315,923
Revenue 92,886 96,782 85,851 82,485
EBITDA 15,656 16,627 13,877 29,259
Net Income (571) 216 (1,531) 16,624
Total Assets 155,109 166,051 156,114 159,433
Total Debt 45,664 47,103 53,134 56,316
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Selvita Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Selvita‘s full profile, request access.

Request a free trial

Selvita Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Selvita SA is a Poland based parent company of Selvita Group is one of the largest preclinical contract research organiz
Drug Discovery
Krakow, Poland
433 As of 2026

Tuebingen, Germany
 

Nottingham, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Selvita Competitors (23)

One of Selvita’s 23 competitors is Immatics, a Formerly VC-backed company based in Tuebingen, Germany.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Immatics Formerly VC-backed Tuebingen, Germany
Sygnature Discovery Private Equity-Backed Nottingham, United Kingdom
Mustang Bio Formerly VC-backed Waltham, MA
WuXi AppTec Formerly PE-Backed Shanghai, China
Rho Corporation Durham, NC
You’re viewing 5 of 23 competitors. Get the full list »

Selvita Patents

  • 16

    Total Documents Applications and Grants

  • Total Patents Families

  • 15

    Granted

  • Pending

  • Expiring in next 12 mo

Selvita Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-11479539-B2 Small molecule modulators of the btb domain of keap1 Active 22-Dec-2017
US-20210094931-A1 Small molecule modulators of the btb domain of keap1 Active 22-Dec-2017
US-20230121578-A1 Small molecule modulators of the btb domain of keap1 Inactive 22-Dec-2017
AU-2017262706-A1 Seco macrolide compounds Active 11-May-2016
AU-2017262706-B2 Seco macrolide compounds Active 11-May-2016 C07H17/08
To view Selvita’s complete patent history, request access »

Selvita Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Selvita Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Selvita‘s full profile, request access.

Request a free trial

Selvita Investments & Acquisitions (5)

Selvita’s most recent deal was a Later Stage VC with Rezera for . The deal was made on 04-Apr-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Rezera 04-Apr-2025 Later Stage VC Drug Discovery
PozLab 06-May-2024 Merger/Acquisition Other Pharmaceuticals and Biotechnology
Fidelta 04-Jan-2021 Merger/Acquisition Drug Discovery
BioCentrum 21-Oct-2010 Secondary Transaction - Private Biotechnology
BioCentrum 31-Mar-2008 Merger/Acquisition Biotechnology
To view Selvita’s complete investments and acquisitions history, request access »

Ready to get started?

Request a free trial

Selvita ESG

Risk Overview

Risk Rating

Updated July, 31, 2025

19.96 | Low Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 14,271

Rank

Percentile

Pharmaceuticals

Industry

of 908

Rank

Percentile

Laboratory Equipment and Services

Subindustry

of 68

Rank

Percentile

To view Selvita’s complete esg history, request access »

Selvita Exits (1)

Selvita’s most recent exit was on 04-Apr-2025 from Rezera. The exit was categorized as with 3 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Rezera 04-Apr-2025 Completed
  • 3 buyers
To view Selvita’s complete exits history, request access »

Selvita FAQs

  • When was Selvita founded?

    Selvita was founded in 2007.

  • Where is Selvita headquartered?

    Selvita is headquartered in Krakow, Poland.

  • What is the size of Selvita?

    Selvita has 433 total employees.

  • What industry is Selvita in?

    Selvita’s primary industry is Drug Discovery.

  • Is Selvita a private or public company?

    Selvita is a Public company.

  • What is Selvita’s stock symbol?

    The ticker symbol for Selvita is SLV.

  • What is the current stock price of Selvita?

    As of 13-Nov-2026 the stock price of Selvita is $4.51.

  • What is the current market cap of Selvita?

    The current market capitalization of Selvita is $82.8M.

  • What is Selvita’s current revenue?

    The trailing twelve month revenue for Selvita is $92.9M.

  • Who are Selvita’s competitors?

    Immatics, Sygnature Discovery, Mustang Bio, WuXi AppTec, and Rho are some of the 23 competitors of Selvita.

  • What is Selvita’s annual earnings per share (EPS)?

    Selvita’s EPS for 12 months was -$0.03.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process